$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Type 17 immunity promotes the exhaustion of CD8 + T cells in cancer 원문보기

Journal for immunotherapy of cancer, v.9 no.6, 2021년, pp.e002603 -   

Kim, Byung-Seok (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) ,  Kuen, Da-Sol (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) ,  Koh, Choong-Hyun (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) ,  Kim, Hyung-Don (Graduate School of Medical Science and Engineering , Korea Advanced Institute of Science and Technology , Daejeon , South Korea) ,  Chang, Seon Hee (Department of Immunology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA) ,  Kim, Sehui (Department of Pathology, Seoul National University Hospital , Seoul National University College of Medicine , Seoul , South Korea) ,  Jeon, Yoon Kyung (Department of Pa) ,  Park, Young-Jun ,  Choi, Garam ,  Kim, Jiyeon ,  Kang, Keon Wook ,  Kim, Hye Young ,  Kang, Suk-Jo ,  Hwang, Shin ,  Shin, Eui-Cheol ,  Kang, Chang-Yuil ,  Dong, Chen ,  Chung, Yeonseok

Abstract AI-Helper 아이콘AI-Helper

BackgroundMultiple types of immune cells producing IL-17 are found in the tumor microenvironment. However, their roles in tumor progression and exhaustion of CD8+ tumor-infiltrating lymphocytes (TILs) remain unclear.MethodsTo determine the role of type 17 immunity in tumor, we investigated the growt...

Keyword

참고문헌 (49)

  1. 1 Binnewies M , Roberts EW , Kersten K , et al . Understanding the tumor immune microenvironment (time) for effective therapy . Nat Med 2018 ; 24 : 541 – 50 . 10.1038/s41591-018-0014-x 29686425 

  2. 2 Gabrilovich DI . Myeloid-derived suppressor cells . Cancer Immunol Res 2017 ; 5 : 3 – 8 . 10.1158/2326-6066.CIR-16-0297 28052991 

  3. 3 Tanaka A , Sakaguchi S . Targeting Treg cells in cancer immunotherapy . Eur J Immunol 2019 ; 49 : 1140 – 6 . 10.1002/eji.201847659 31257581 

  4. 4 Zhao J , Chen X , Herjan T , et al . The role of interleukin-17 in tumor development and progression . J Exp Med 2020 ; 217 . 10.1084/jem.20190297 . [Epub ahead of print: 06 Jan 2020 ]. 

  5. 5 Langowski JL , Zhang X , Wu L , et al . IL-23 promotes tumour incidence and growth . Nature 2006 ; 442 : 461 – 5 . 10.1038/nature04808 16688182 

  6. 6 Purwar R , Schlapbach C , Xiao S , et al . Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells . Nat Med 2012 ; 18 : 1248 – 53 . 10.1038/nm.2856 22772464 

  7. 7 Chang SH , Mirabolfathinejad SG , Katta H , et al . T helper 17 cells play a critical pathogenic role in lung cancer . Proc Natl Acad Sci U S A 2014 ; 111 : 5664 – 9 . 10.1073/pnas.1319051111 24706787 

  8. 8 Numasaki M , Fukushi J-ichi , Ono M , et al . Interleukin-17 promotes angiogenesis and tumor growth . Blood 2003 ; 101 : 2620 – 7 . 10.1182/blood-2002-05-1461 12411307 

  9. 9 Wang S , Li Zhi'an , Hu G . Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis . Oncotarget 2017 ; 8 : 66382 – 91 . 10.18632/oncotarget.18807 29029520 

  10. 10 Chen J-gao , Xia J-chuan , Liang X-ting , et al . Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients . Int J Biol Sci 2011 ; 7 : 53 – 60 . 10.7150/ijbs.7.53 21234303 

  11. 11 Han Y , Ye A , Bi L , et al . Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia . Cancer Sci 2014 ; 105 : 933 – 42 . 10.1111/cas.12459 24890519 

  12. 12 Martin-Orozco N , Muranski P , Chung Y , et al . T helper 17 cells promote cytotoxic T cell activation in tumor immunity . Immunity 2009 ; 31 : 787 – 98 . 10.1016/j.immuni.2009.09.014 19879162 

  13. 13 Yu Y , Cho H-I , Wang D , et al . Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms . J Immunol 2013 ; 190 : 1873 – 81 . 10.4049/jimmunol.1201989 23315072 

  14. 14 Hu X , Liu X , Moisan J , et al . Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity . Oncoimmunology 2016 ; 5 : e1254854 . 10.1080/2162402X.2016.1254854 28123897 

  15. 15 Kryczek I , Wei S , Szeliga W , et al . Endogenous IL-17 contributes to reduced tumor growth and metastasis . Blood 2009 ; 114 : 357 – 9 . 10.1182/blood-2008-09-177360 19289853 

  16. 16 Jain P , Javdan M , Feger FK , et al . Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance . Haematologica 2012 ; 97 : 599 – 607 . 10.3324/haematol.2011.047316 22058222 

  17. 17 Punt S , van Vliet ME , Spaans VM , et al . FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma . Cancer Immunol Immunother 2015 ; 64 : 745 – 53 . 10.1007/s00262-015-1678-4 25795131 

  18. 18 McLane LM , Abdel-Hakeem MS , Wherry EJ . CD8 T cell exhaustion during chronic viral infection and cancer . Annu Rev Immunol 2019 ; 37 : 457 – 95 . 10.1146/annurev-immunol-041015-055318 30676822 

  19. 19 Miller BC , Sen DR , Al Abosy R , et al . Subsets of exhausted CD8 + T cells differentially mediate tumor control and respond to checkpoint blockade . Nat Immunol 2019 ; 20 : 326 – 36 . 10.1038/s41590-019-0312-6 30778252 

  20. 20 Siddiqui I , Schaeuble K , Chennupati V , et al . Intratumoral Tcf1 + PD-1 + CD8 + T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy . Immunity 2019 ; 50 : e10 : 195 – 211 . 10.1016/j.immuni.2018.12.021 

  21. 21 Kim K , Park S , Park SY , et al . Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer . Genome Med 2020 ; 12 : 22 . 10.1186/s13073-020-00722-9 32111241 

  22. 22 Wherry EJ , Kurachi M . Molecular and cellular insights into T cell exhaustion . Nat Rev Immunol 2015 ; 15 : 486 – 99 . 10.1038/nri3862 26205583 

  23. 23 Kim JM , Rasmussen JP , Rudensky AY . Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice . Nat Immunol 2007 ; 8 : 191 – 7 . 10.1038/ni1428 17136045 

  24. 24 Song B , Lee J-M , Park Y-J , et al . Differentiation of c-Kit + CD24 + natural killer cells into myeloid cells in a GATA-2-dependent manner . Faseb J 2020 ; 34 : 4462 – 81 . 10.1096/fj.201902662R 31989715 

  25. 25 Cho Y , Kwon D , Kang S-J . The cooperative role of CD326 + and CD11b + dendritic cell subsets for a hapten-induced Th2 differentiation . J Immunol 2017 ; 199 : 3137 – 46 . 10.4049/jimmunol.1601262 28972093 

  26. 26 Kim H-D , Song G-W , Park S , et al . Association between expression level of PD1 by tumor-infiltrating CD8 + T cells and features of hepatocellular carcinoma . Gastroenterology 2018 ; 155 : e17 : 1936 – 50 . 10.1053/j.gastro.2018.08.030 

  27. 27 Park Y-J , Ryu H , Choi G , et al . IL-27 confers a protumorigenic activity of regulatory T cells via CD39 . Proc Natl Acad Sci U S A 2019 ; 116 : 3106 – 11 . 10.1073/pnas.1810254116 30718407 

  28. 28 Ciofani M , Madar A , Galan C , et al . A validated regulatory network for Th17 cell specification . Cell 2012 ; 151 : 289 – 303 . 10.1016/j.cell.2012.09.016 23021777 

  29. 29 Doering TA , Crawford A , Angelosanto JM , et al . Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory . Immunity 2012 ; 37 : 1130 – 44 . 10.1016/j.immuni.2012.08.021 23159438 

  30. 30 Singer M , Wang C , Cong L , et al . A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells . Cell 2016 ; 166 : 1500 – 11 . 10.1016/j.cell.2016.08.052 27610572 

  31. 31 Ahrends T , Spanjaard A , Pilzecker B , et al . CD4 + T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness . Immunity 2017 ; 47 : 848 – 61 . 10.1016/j.immuni.2017.10.009 29126798 

  32. 32 Amsen D , van Gisbergen KPJM , Hombrink P , et al . Tissue-Resident memory T cells at the center of immunity to solid tumors . Nat Immunol 2018 ; 19 : 538 – 46 . 10.1038/s41590-018-0114-2 29777219 

  33. 33 Lee YK , Turner H , Maynard CL , et al . Late developmental plasticity in the T helper 17 lineage . Immunity 2009 ; 30 : 92 – 107 . 10.1016/j.immuni.2008.11.005 19119024 

  34. 34 Yen H-R , Harris TJ , Wada S , et al . Tc17 CD8 T cells: functional plasticity and subset diversity . J Immunol 2009 ; 183 : 7161 – 8 . 10.4049/jimmunol.0900368 19917680 

  35. 35 Kim B-S , Park Y-J , Chung Y . Targeting IL-17 in autoimmunity and inflammation . Arch Pharm Res 2016 ; 39 : 1537 – 47 . 10.1007/s12272-016-0823-8 27576555 

  36. 36 Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming . Nat Rev Immunol 2008 ; 8 : 337 – 48 . 10.1038/nri2295 18408735 

  37. 37 Codarri L , Gyülvészi G , Tosevski V , et al . Rorγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation . Nat Immunol 2011 ; 12 : 560 – 7 . 10.1038/ni.2027 21516112 

  38. 38 Ivanov II , McKenzie BS , Zhou L , et al . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells . Cell 2006 ; 126 : 1121 – 33 . 10.1016/j.cell.2006.07.035 16990136 

  39. 39 Xu T , Wang X , Zhong B , et al . Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma T protein . J Biol Chem 2011 ; 286 : 22707 – 10 . 10.1074/jbc.C111.250407 21566134 

  40. 40 Llosa NJ , Luber B , Tam AJ , et al . Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors . Clin Cancer Res 2019 ; 25 : 5250 – 9 . 10.1158/1078-0432.CCR-19-0114 31061070 

  41. 41 Gopalakrishnan V , Spencer CN , Nezi L , et al . Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients . Science 2018 ; 359 : 97 – 103 . 10.1126/science.aan4236 29097493 

  42. 42 Nagaoka K , Shirai M , Taniguchi K , et al . Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy . J Immunother Cancer 2020 ; 8 : e001358 . 10.1136/jitc-2020-001358 33093158 

  43. 43 Liu C , Liu R , Wang B , et al . Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer . J Immunother Cancer 2021 ; 9 . 10.1136/jitc-2020-001895 

  44. 44 Kong X , Sun R , Chen Y , et al . γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance . J Immunol 2014 ; 193 : 1645 – 53 . 10.4049/jimmunol.1303432 25015833 

  45. 45 Tao J , Han D , Gao S , et al . CD8 + T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal-9 pathway . J Cell Mol Med 2020 ; 24 : 1046 – 58 . 10.1111/jcmm.14825 31756785 

  46. 46 Tosello Boari J , Araujo Furlan CL , Fiocca Vernengo F , et al . IL-17RA-signaling modulates CD8+ T cell survival and exhaustion during Trypanosoma cruzi infection . Front Immunol 2018 ; 9 : 2347 . 10.3389/fimmu.2018.02347 30364284 

  47. 47 Zander R , Schauder D , Xin G , et al . CD4 + T cell help is required for the formation of a cytolytic CD8 + T cell subset that protects against chronic infection and cancer . Immunity 2019 ; 51 : 1028 – 42 . 10.1016/j.immuni.2019.10.009 31810883 

  48. 48 Hudson WH , Gensheimer J , Hashimoto M , et al . Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1 + stem-like CD8 + T cells during chronic infection . Immunity 2019 ; 51 : 1043 – 58 . 10.1016/j.immuni.2019.11.002 31810882 

  49. 49 Ueha S , Yokochi S , Ishiwata Y , et al . Robust antitumor effects of combined anti-CD4-depleting antibody and anti-PD-1/PD-L1 immune checkpoint antibody treatment in mice . Cancer Immunol Res 2015 ; 3 : 631 – 40 . 10.1158/2326-6066.CIR-14-0190 25711759 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로